Tensin 4 facilitates aerobic glycolysis, migration and invasion of colorectal cancer cells through the &beta;‑catenin/c‑Myc signaling pathway

Wang,Yan; Lu,Yongda; Xu,Chunfang

doi:10.3892/ol.2024.14489

Tensin 4 facilitates aerobic glycolysis, migration and invasion of colorectal cancer cells through the β‑catenin/c‑Myc signaling pathway

Authors:
- Yan Wang
- Yongda Lu
- Chunfang Xu
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, P.R. China
Published online on: June 3, 2024 https://doi.org/10.3892/ol.2024.14489
Article Number: 356
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tensin 4 (TNS4) is overexpressed in multiple cancers, including colorectal cancer (CRC), and is associated with a poor prognosis of patients with CRC. However, the role and underlying mechanisms of TNS4 in CRC have yet to be elucidated. The expression of TNS4 in CRC tissues were analyzed by immunohistochemistry. Cell migration and invasion were assessed in vitro using Transwell assay. Western blot and reverse transcription (RT)‑quantitative (q)PCR were used to investigate the molecular mechanisms by which TNS4 regulates aerobic glycolysis, migration and invasion of CRC cells. The present study demonstrated that TNS4 was highly expressed in the cancer tissues of patients with CRC and significantly associated with the tumor‑node‑metastasis stages. TNS4 silencing led to a significant decrease in glucose consumption and lactate production in CRC cells, and knockdown of TNS4 suppressed the migration and invasion of CRC cells via aerobic glycolysis through the β‑catenin/c‑Myc pathway. Notably, treatment with DASA‑58, an activator of glycolysis, or SKL2001, an activator of β‑catenin/c‑Myc signaling, significantly reversed the effect of TNS4 knockdown on aerobic glycolysis, migration and invasion of CRC cells. Collectively, these results suggest that TNS4 may act as a novel regulator of aerobic glycolysis, migration and invasion of CRC cells by modulating β‑catenin/c‑Myc signaling, providing a new potential biomarker and therapeutic target in CRC.

View Figures

View References

1	Biller LH and Schrag D: Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA. 325:669–685. 2021. View Article : Google Scholar : PubMed/NCBI
2	Piawah S and Venook AP: Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 125:4139–4147. 2019. View Article : Google Scholar : PubMed/NCBI
3	Holladay L, Luu J, Balendra V and Kmetz K: Current and potential treatment of colorectal cancer metastasis to bone. Cancer Treat Res Commun. 37:1007632023. View Article : Google Scholar : PubMed/NCBI
4	Lo SH: C-terminal tensin-like (CTEN): A promising biomarker and target for cancer. Int J Biochem Cell Biol. 51:150–154. 2014. View Article : Google Scholar : PubMed/NCBI
5	Lu X, Zhou B, Cao M, Shao Q, Pan Y and Zhao T: CTEN inhibits tumor angiogenesis and growth by targeting VEGFA through down-regulation of β-catenin in breast cancer. Technol Cancer Res Treat. 20:153303382110455062021. View Article : Google Scholar : PubMed/NCBI
6	Al-Ghamdi S, Cachat J, Albasri A, Ahmed M, Jackson D, Zaitoun A, Guppy N, Otto WR, Alison MR, Kindle KB and Ilyas M: C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer. Pancreas. 42:135–140. 2013. View Article : Google Scholar : PubMed/NCBI
7	Sasaki H, Moriyama S, Mizuno K, Yukiue H, Konishi A, Yano M, Kaji M, Fukai I, Kiriyama M, Yamakawa Y and Fujii Y: Cten mRNA expression was correlated with tumor progression in lung cancers. Lung Cancer. 40:151–155. 2003. View Article : Google Scholar : PubMed/NCBI
8	Albasri A, Al-Ghamdi S, Fadhil W, Aleskandarany M, Liao YC, Jackson D, Lobo DN, Lo SH, Kumari R, Durrant L, et al: Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer. Oncogene. 30:2997–3002. 2011. View Article : Google Scholar : PubMed/NCBI
9	Asiri A, Toss MS, Raposo TP, Akhlaq M, Thorpe H, Alfahed A, Asiri A and Ilyas M: Cten promotes epithelial-mesenchymal transition (EMT) in colorectal cancer through stabilisation of Src. Pathol Int. 69:381–391. 2019. View Article : Google Scholar : PubMed/NCBI
10	Thorpe H, Asiri A, Akhlaq M and Ilyas M: Cten promotes epithelial-mesenchymal transition through the post-transcriptional stabilization of Snail. Mol Carcinog. 56:2601–2609. 2017. View Article : Google Scholar : PubMed/NCBI
11	Lu X, Gao J, Zhang Y, Zhao T, Cai H and Zhang T: CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells. PLoS One. 13:e01988232018. View Article : Google Scholar : PubMed/NCBI
12	Albasri A, Seth R, Jackson D, Benhasouna A, Crook S, Nateri AS, Chapman R and Ilyas M: C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. J Pathol. 218:57–65. 2019. View Article : Google Scholar : PubMed/NCBI
13	Wang YX, Huang CY, Chiu HJ, Huang PH, Chien HT, Jwo SH and Liao YC: Nuclear-localized CTEN is a novel transcriptional regulator and promotes cancer cell migration through its downstream target CDC27. J Physiol Biochem. 79:163–174. 2023. View Article : Google Scholar : PubMed/NCBI
14	Lu X, Zhang Y, Pan Y, Cao M, Zhou X and Zhang T: Overexpression of CTEN is associated with gefitinib resistance in non-small cell lung cancer. Oncol Lett. 21:402021.PubMed/NCBI
15	Li Y, Mizokami A, Izumi K, Narimoto K, Shima T, Zhang J, Dai J, Keller ET and Namiki M: CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer. Prostate. 70:48–60. 2010. View Article : Google Scholar : PubMed/NCBI
16	Liao YC, Chen NT, Shih YP, Dong Y and Lo SH: Up-regulation of C-terminal tensin-like molecule promotes the tumorigenicity of colon cancer through beta-catenin. Cancer Res. 69:4563–4566. 2009. View Article : Google Scholar : PubMed/NCBI
17	Schwartz L, Supuran CT and Alfarouk KO: The Warburg effect and the hallmarks of cancer. Anticancer Agents Med Chem. 17:164–170. 2017. View Article : Google Scholar : PubMed/NCBI
18	Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S, Wei P and Li D: Warburg effect in colorectal cancer: The emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol. 15:1602022. View Article : Google Scholar : PubMed/NCBI
19	Liu J, Liu ZX, Wu QN, Lu YX, Wong CW, Miao L, Wang Y, Wang Z, Jin Y, He MM, et al: Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming. Nat Commun. 11:15072020. View Article : Google Scholar : PubMed/NCBI
20	Yu S, Zang W, Qiu Y, Liao L and Zheng X: Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis. Oncogene. 41:46–56. 2022. View Article : Google Scholar : PubMed/NCBI
21	Shi T, Ma Y, Cao L, Zhan S, Xu Y, Fu F, Liu C, Zhang G, Wang Z, Wang R, et al: B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2. Cell Death Dis. 10:3082019. View Article : Google Scholar : PubMed/NCBI
22	Liu M, Huang F, Zhang D, Ju J, Wu XB, Wang Y, Wang Y, Wu Y, Nie M, Li Z, et al: Heterochromatin protein HP1gamma promotes colorectal cancer progression and is regulated by miR-30a. Cancer Res. 75:4593–4604. 2015. View Article : Google Scholar : PubMed/NCBI
23	Chen Z, Hu Z, Sui Q, Huang Y, Zhao M, Li M, Liang J, Lu T, Zhan C, Lin Z, et al: LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/glycolysis axis in lung adenocarcinoma. Int J Biol Sci. 18:522–535. 2022. View Article : Google Scholar : PubMed/NCBI
24	Lin S, Li Y, Wang D, Huang C, Marino D, Bollt O, Wu C, Taylor MD, Li W, DeNicola GM, et al: Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression. Cancer Lett. 518:230–242. 2021. View Article : Google Scholar : PubMed/NCBI
25	Rao J, Wang H, Ni M, Wang Z, Wang Z, Wei S, Liu M, Wang P, Qiu J, Zhang L, et al: FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut. 71:2539–2550. 2022. View Article : Google Scholar : PubMed/NCBI
26	Liu R, Li Y, Tian L, Shi H, Wang J, Liang Y, Sun B, Wang S, Zhou M, Wu L, et al: Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma. Cancer Lett. 443:34–46. 2019. View Article : Google Scholar : PubMed/NCBI
27	Dai M, Song J, Wang L, Zhou K and Shu L: HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through β-catenin/c-Myc signaling pathway. J Bioenerg Biomembr. 53:597–608. 2021. View Article : Google Scholar : PubMed/NCBI
28	Liu Y, Huang Y, Zhang J, Pei C, Hu J, Lyu J and Shen Y: TIMMDC1 knockdown inhibits growth and metastasis of gastric cancer cells through metabolic inhibition and AKT/GSK3β/β-catenin signaling pathway. Int J Biol Sci. 14:1256–1267. 2018. View Article : Google Scholar : PubMed/NCBI
29	Rennoll S and Yochum G: Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer. World J Biol Chem. 6:290–300. 2015. View Article : Google Scholar : PubMed/NCBI
30	Ashihara E, Takada T and Maekawa T: Targeting the canonical Wnt/β-catenin pathway in hematological malignancies. Cancer Sci. 106:665–671. 2015. View Article : Google Scholar : PubMed/NCBI
31	Wu YB, Li SY, Liu JY, Xue JJ, Xu JF, Chen T, Cao TY, Zhou H, Wu TT, Dong CL, et al: Long non-coding RNA NRSN2-AS1 promotes ovarian cancer progression through targeting PTK2/β-catenin pathway. Cell Death Dis. 14:6962023. View Article : Google Scholar : PubMed/NCBI
32	Liao YC and Lo SH: Tensins-emerging insights into their domain functions, biological roles and disease relevance. J Cell Sci. 134:jcs2540292021. View Article : Google Scholar : PubMed/NCBI
33	Zafari N, Velayati M, Damavandi S, Pourali G, Mobarhan MG, Nassiri M, Hassanian SM, Khazaei M, Ferns GA and Avan A: Metabolic pathways regulating colorectal cancer: A potential therapeutic approach. Curr Pharm Des. 28:2995–3009. 2022. View Article : Google Scholar : PubMed/NCBI
34	Nenkov M, Ma Y, Gaßler N and Chen Y: Metabolic reprogramming of colorectal cancer cells and the microenvironment: Implication for therapy. Int J Mol Sci. 22:62622021. View Article : Google Scholar : PubMed/NCBI
35	Zhao S, Guan B, Mi Y, Shi D, Wei P, Gu Y, Cai S, Xu Y, Li X, Yan D, et al: LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit. Oncogene. 40:4709–4724. 2021. View Article : Google Scholar : PubMed/NCBI
36	Asiri A, Raposo TP, Alfahed A and Ilyas M: TGFβ1-induced cell motility but not cell proliferation is mediated through Cten in colorectal cancer. Int J Exp Pathol. 99:323–330. 2018. View Article : Google Scholar : PubMed/NCBI
37	Fleming JC, Woo J, Moutasim K, Hanley CJ, Frampton SJ, Wood O, Ward M, Woelk CH, Ottensmeier CH, Hafizi S, et al: CTEN induces tumour cell invasion and survival and is prognostic in radiotherapy-treated head and neck cancer. Cancers (Basel). 12:29632020. View Article : Google Scholar : PubMed/NCBI
38	Yang J, Ren B, Yang G, Wang H, Chen G, You L, Zhang T and Zhao Y: The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 77:305–321. 2020. View Article : Google Scholar : PubMed/NCBI
39	Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, Dai W and Guo C: Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 39:1262020. View Article : Google Scholar : PubMed/NCBI
40	Fang Y, Shen ZY, Zhan YZ, Feng XC, Chen KL, Li YS, Deng HJ, Pan SM, Wu DH and Ding Y: CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 10:39812019. View Article : Google Scholar : PubMed/NCBI
41	Liang Y, Rao Z, Du D, Wang Y and Fang T: Butyrate prevents the migration and invasion, and aerobic glycolysis in gastric cancer via inhibiting Wnt/β-catenin/c-Myc signaling. Drug Dev Res. 84:532–541. 2023. View Article : Google Scholar : PubMed/NCBI
42	Raposo TP, Alfahed A, Nateri AS and Ilyas M: Tensin4 (TNS4) is upregulated by Wnt signalling in adenomas in multiple intestinal neoplasia (Min) mice. Int J Exp Pathol. 101:80–86. 2020. View Article : Google Scholar : PubMed/NCBI